Literature DB >> 25490271

Identifying protein-protein interaction sites using peptide arrays.

Hadar Amartely1, Anat Iosub-Amir1, Assaf Friedler2.   

Abstract

Protein-protein interactions mediate most of the processes in the living cell and control homeostasis of the organism. Impaired protein interactions may result in disease, making protein interactions important drug targets. It is thus highly important to understand these interactions at the molecular level. Protein interactions are studied using a variety of techniques ranging from cellular and biochemical assays to quantitative biophysical assays, and these may be performed either with full-length proteins, with protein domains or with peptides. Peptides serve as excellent tools to study protein interactions since peptides can be easily synthesized and allow the focusing on specific interaction sites. Peptide arrays enable the identification of the interaction sites between two proteins as well as screening for peptides that bind the target protein for therapeutic purposes. They also allow high throughput SAR studies. For identification of binding sites, a typical peptide array usually contains partly overlapping 10-20 residues peptides derived from the full sequences of one or more partner proteins of the desired target protein. Screening the array for binding the target protein reveals the binding peptides, corresponding to the binding sites in the partner proteins, in an easy and fast method using only small amount of protein. In this article we describe a protocol for screening peptide arrays for mapping the interaction sites between a target protein and its partners. The peptide array is designed based on the sequences of the partner proteins taking into account their secondary structures. The arrays used in this protocol were Celluspots arrays prepared by INTAVIS Bioanalytical Instruments. The array is blocked to prevent unspecific binding and then incubated with the studied protein. Detection using an antibody reveals the binding peptides corresponding to the specific interaction sites between the proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25490271      PMCID: PMC4354139          DOI: 10.3791/52097

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  Peptide and small molecule microarray for high throughput cell adhesion and functional assays.

Authors:  J R Falsey; M Renil; S Park; S Li; K S Lam
Journal:  Bioconjug Chem       Date:  2001 May-Jun       Impact factor: 4.774

2.  The STIL protein contains intrinsically disordered regions that mediate its protein-protein interactions.

Authors:  Hadar Amartely; Ahuvit David; Mario Lebendiker; Hadar Benyamini; Shai Izraeli; Assaf Friedler
Journal:  Chem Commun (Camb)       Date:  2013-09-11       Impact factor: 6.222

Review 3.  Studying protein-protein interactions using peptide arrays.

Authors:  Chen Katz; Liron Levy-Beladev; Shahar Rotem-Bamberger; Tiago Rito; Stefan G D Rüdiger; Assaf Friedler
Journal:  Chem Soc Rev       Date:  2011-01-18       Impact factor: 54.564

4.  Expression of the SIL gene is correlated with growth induction and cellular proliferation.

Authors:  S Izraeli; T Colaizzo-Anas; V L Bertness; K Mani; P D Aplan; I R Kirsch
Journal:  Cell Growth Differ       Date:  1997-11

5.  Isotope or mass encoding of combinatorial libraries.

Authors:  H M Geysen; C D Wagner; W M Bodnar; C J Markworth; G J Parke; F J Schoenen; D S Wagner; D S Kinder
Journal:  Chem Biol       Date:  1996-08

6.  Cell-cycle-regulated expression of STIL controls centriole number in human cells.

Authors:  Christian Arquint; Katharina F Sonnen; York-Dieter Stierhof; Erich A Nigg
Journal:  J Cell Sci       Date:  2012-02-20       Impact factor: 5.285

7.  The SIL gene is required for mouse embryonic axial development and left-right specification.

Authors:  S Izraeli; L A Lowe; V L Bertness; D J Good; D W Dorward; I R Kirsch; M R Kuehn
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

8.  SCL/TAL1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cell.

Authors:  Kenji Kasai; Shingo Inaguma; Akiko Yoneyama; Kazuhiro Yoshikawa; Hiroshi Ikeda
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines.

Authors:  K A Olaussen; F Commo; M Tailler; L Lacroix; I Vitale; S Q Raza; C Richon; P Dessen; V Lazar; J-C Soria; G Kroemer
Journal:  Oncogene       Date:  2009-09-14       Impact factor: 9.867

10.  Identification and mapping of linear antibody epitopes in human serum albumin using high-density Peptide arrays.

Authors:  Lajla Bruntse Hansen; Soren Buus; Claus Schafer-Nielsen
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more
  4 in total

1.  Arrestin-3 interaction with maternal embryonic leucine-zipper kinase.

Authors:  Nicole A Perry; Kevin P Fialkowski; Tamer S Kaoud; Ali I Kaya; Andrew L Chen; Juliana M Taliaferro; Vsevolod V Gurevich; Kevin N Dalby; T M Iverson
Journal:  Cell Signal       Date:  2019-07-25       Impact factor: 4.315

2.  Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation.

Authors:  Pan Liu; Tomokazu Souma; Andrew Zu-Sern Wei; Xueying Xie; Xunrong Luo; Jing Jin
Journal:  J Vis Exp       Date:  2017-09-06       Impact factor: 1.355

3.  Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction.

Authors:  Amit Mahindra; Gonzalo Tejeda; Mario Rossi; Omar Janha; Imogen Herbert; Caroline Morris; Danielle C Morgan; Wendy Beattie; Augusto C Montezano; Brian Hudson; Andrew B Tobin; David Bhella; Rhian M Touyz; Andrew G Jamieson; George S Baillie; Connor M Blair
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

4.  Optimal His-Tag Design for Efficient [99mTc(CO)3]+ and [188Re(CO)3]+ Labeling of Proteins for Molecular Imaging and Radionuclide Therapy by Analysis of Peptide Arrays.

Authors:  Jennifer D Williams; Florian Kampmeier; Adam Badar; Kevin Howland; Margaret S Cooper; Gregory E D Mullen; Philip J Blower
Journal:  Bioconjug Chem       Date:  2020-11-26       Impact factor: 4.774

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.